Education
About Us
Working with TipRanks
Follow Us
Zaffirios Zygouras Insider Profile
4 Followers
Zaffirios Zygouras, Senior Officer at Neupath Health Inc., holds 206.78K shares in Neupath Health Inc. (Ticker: TSE:NPTH).
Zaffirios Zygouras Neupath Health Inc. (NPTH)Senior Officer
Neupath Health Inc. (NPTH)
Senior Officer
Ranked #10,637 out of 105,077 Corporate Insiders
Profitable Transactions
3 out of 3 Profitable Transactions
Average Return
+93.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Zaffirios Zygouras's holdings
Insider Roles
Senior Officer
Roles that Zaffirios Zygouras holds in companies
Most Profitable Insider Trade
The most profitable trade made by Zaffirios Zygouras
Zaffirios Zygouras's Trading History
List of latest transactions for each holding click on a transaction to see Zaffirios Zygouras's performance on stock
You May Also Like
Zaffirios Zygouras insider profile FAQ
What is the percentage of profitable transactions made by Zaffirios Zygouras?
The percentage of profitable transactions made by Zaffirios Zygouras is 100%.
What is the average return per transaction made by Zaffirios Zygouras?
The average return per transaction made by Zaffirios Zygouras is 93.70%.
What stocks does Zaffirios Zygouras hold?
Zaffirios Zygouras holds: TSE:NPTH stocks.
What was Zaffirios Zygouras’s latest transaction?
Zaffirios Zygouras latest transaction was an Uninformative Buy of C$6.56K.
What was Zaffirios Zygouras's most profitable transaction?
Zaffirios Zygouras’s most profitable transaction was an Informative Buy of TSE:NPTH stock on April 2, 2025. The return on the trade was 125.60%.
What is Zaffirios Zygouras's role in Neupath Health Inc.?
Zaffirios Zygouras's role in Neupath Health Inc. is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.